With the economy's globalization and the population's aging, cancer has become the
leading cause of death in most countries. While imposing a considerable burden on society …

Cancer is a major burden on the healthcare system, and new therapies are needed.
Recently, the development of immunotherapies, which aim to boost or use the immune …

Cytokine-induced killer (CIK) cells are a heterogeneous population of effector CD3+ CD56+
natural killer T cells, which can be easily expanded in vitro from peripheral blood …

As a widely studied adoptive treatment method, CIK (cytokine-induced killer cells) treatment
has shown clinical benefits in many clinical trials on non-small cell lung cancer. As a …

Immunotherapies have revolutionized the treatment paradigms of various types of cancers.
However, most of these immunomodulatory strategies focus on harnessing adaptive …

Hepatocellular carcinoma (HCC) is a lethal malignancy with poor prognosis. More than 80%
of patients are diagnosed at an advanced stage, and most patients with HCC also have liver …

Background & Aims Inflammation in the liver provokes fibrosis, but inflammation is also
important for tumor surveillance. Inhibitors of chemokine pathways, such as CXCL16 and …

The introduction of advanced therapy medicinal products (ATMPs) to the global pharma
market has been revolutionizing the pharmaceutical industry and has opened new routes for …

肝癌发生发展机制的研究进展及其治疗现状 Page 1 第27 卷第7 期 2018 年7 月 中国普通外科
杂志 Chinese Journal of General Surgery Vol.27 No.7 Jul. 2018 © 版权归中国普通外科杂志 …

Hepatocellular carcinoma (HCC) is the most common primary liver neoplasm and one of the
most common causes of death in patients with cirrhosis of the liver. In parallel with …